How Relevant is the Interaction Between Dolutegravir and Metformin in Real Life?

J Acquir Immune Defic Syndr. 2017 May 1;75(1):e24-e26. doi: 10.1097/QAI.0000000000001292.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Area Under Curve
  • CD4 Lymphocyte Count
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Drug Interactions
  • Drug Therapy, Combination
  • Female
  • Glycated Hemoglobin / drug effects
  • HIV Infections / drug therapy*
  • HIV Integrase Inhibitors / pharmacokinetics*
  • HIV Integrase Inhibitors / therapeutic use
  • Heterocyclic Compounds, 3-Ring / pharmacokinetics*
  • Heterocyclic Compounds, 3-Ring / therapeutic use
  • Humans
  • Hypoglycemic Agents / pharmacokinetics*
  • Hypoglycemic Agents / therapeutic use
  • Male
  • Metformin / pharmacokinetics*
  • Metformin / therapeutic use
  • Middle Aged
  • Oxazines
  • Piperazines
  • Pyridones
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Glycated Hemoglobin A
  • HIV Integrase Inhibitors
  • Heterocyclic Compounds, 3-Ring
  • Hypoglycemic Agents
  • Oxazines
  • Piperazines
  • Pyridones
  • hemoglobin A1c protein, human
  • Metformin
  • dolutegravir